Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies

Ramon V. Tiu, Lukasz P. Gondek, Christine L. O'Keefe, Paul Elson, Jungwon Huh, Azim Mohamedali, Austin Kulasekararaj, Anjali S. Advani, Ronald Paquette, Alan F. List, Mikkael A. Sekeres, Michael A. McDevitt, Ghulam J. Mufti, Jaroslaw P. Maciejewski

Research output: Contribution to journalArticlepeer-review

178 Scopus citations


Single nucleotide polymorphism arrays (SNP-As) have emerged as an important tool in the identification of chromosomal defects undetected by metaphase cytogenetics (MC) in hematologic cancers, offering superior resolution of unbalanced chromosomal defects and acquired copyneutral loss of heterozygosity. Myelodysplastic syndromes (MDSs) and related cancers share recurrent chromosomal defects and molecular lesions that predict outcomes. We hypothesized that combining SNP-A and MC could improve diagnosis/prognosis and further the molecular characterization of myeloid malignancies. We analyzed MC/SNP-A results from 430 patients (MDS = 250, MDS/myeloproliferative overlap neoplasm = 95, acute myeloid leukemia from MDS = 85). The frequency and clinical significance of genomic aberrations was compared between MC and MC plus SNP-A. Combined MC/SNP-A karyotyping lead to higher diagnostic yield of chromosomal defects (74% vs 44%, P < .0001), compared with MCalone, often through detection of novel lesions in patients with normal/noninformative (54%) and abnormal (62%) MC results. Newly detected SNP-A defects contributed to poorer prognosis for patients stratified by current morphologic and clinical risk schemes. The presence and number of new SNP-A detected lesions are independent predictors of overall and event-free survival. The significant diagnostic and prognostic contributions of SNP-A-detected defects in MDS and related diseases underscore the utility of SNP-A when combined with MC in hematologic malignancies.

Original languageEnglish
Pages (from-to)4552-4560
Number of pages9
Issue number17
StatePublished - 28 Apr 2011


Dive into the research topics of 'Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies'. Together they form a unique fingerprint.

Cite this